Ascentage Pharma Group International AAPG
NASDAQ AAPG
$15.80 -0.11 (-0.69%)
As of: Oct 21, 2026 · 11:33 AM EDT

Ascentage Pharma Group International (AAPG) Enterprise Value (2025 - 2026)

Updated

Ascentage Pharma Group International (AAPG) recorded Enterprise Value of $1.36 billion in Q2 2026, down 57.5% from $3.2 billion a year earlier.

Analysis

Ascentage Pharma Group International (AAPG) Enterprise Value (2025 - 2026) Analysis & Trends

On a TTM basis, Ascentage Pharma Group International's Enterprise Value came in at $607.35 million as of Jun 30, 2026, down 77.4% year-over-year; for FY2025, it was $2.11 billion.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,134.13 Bn 1,102.72 Bn 19.71 Bn
2 Johnson & Johnson 616.20 Bn 534.73 Bn 17.26 Bn
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn
5 Novartis Ag 297.88 Bn 261.87 Bn 11.24 Bn
6 Astrazeneca 261.36 Bn 235.05 Bn 12.86 Bn
7 Amgen 235.80 Bn 191.20 Bn 7.24 Bn
8 Gilead Sciences 190.78 Bn 164.97 Bn 6.22 Bn
9 Pfizer 169.43 Bn 116.08 Bn 10.94 Bn
10 Ascentage Pharma Group International 1.41 Bn 369.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.36 Bn
Dec 31, 2025 2.10 Bn
Jun 30, 2025 3.20 Bn
API Access

Ascentage Pharma Group International Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=AAPG&period=max&api_key=YOUR_API_KEY